Abstract:Abstract Introduction C. difficile colitis (C diff colitis) is identified in up to 500k infections/year in the US, with up to 30,000 people per year dying with the diagnosis. Previous studies established risk factors for this condition including long-term antibiotic use. Burn patients are typically exposed to many antibiotics over long periods of time, and may have lengthy hospitalizations similar to other critically ill patients. Neither of these populations have been studied in terms of C diff colitis, risk and outcomes alike. Our aim is to compare C diff colitis rates among critically ill and non-critically ill burn populations, and to investigate the use of antibiotics prior to diagnosis. Methods All analyses were generated with TriNetX platform software (TriNetX, Cambridge, MA) in 2023. We compared incidence of C diff colitis in non-critically ill and critically ill burn populations, and non-burn injury control groups. Cohorts were propensity matched for age at diagnosis, sex, and race/ethnicity. The difference between groups was tested using the log-rank test and quantified with hazard ratios (95% CI), calculated with TriNetX Analytics features. We examined length of hospital stay of cohorts, antibiotic use prior to C diff colitis diagnosis, death within 1 year, and colectomy/toxic megacolon diagnosis. Results We found critically ill patients are diagnosed with C diff colitis at similar rates (OR = 1.065, 95% CI = 0.89, 1.276), but non-critically ill burn patients have a higher rate of C diff colitis compared to non-burn injury counterparts (OR = 1.713, 95% CI = 1.471, 1.995). Antibiotics use up to 2 weeks prior to C diff colitis diagnosis was higher in C diff colitis patients in all four cohorts. Specifically for critically ill burn C diff colitis patients, penicillin (p=0.0072), quinolones (p< 0.0001), tetracyclines (p=0.0037), trimethoprim (p=0.0011), vancomycin (p< 0.0001), clindamycin (p< 0.0357), metronidazole (p< 0.0001), and sulfonamides (p=0.0005) were all given more frequently as compared to counterparts without C diff colitis. Conclusions Critically ill burn patients are at an increased risk of C diff colitis compared to non-critically ill burn, as are critically ill non-burn patients. C diff colitis remains significantly associated with antibiotic use, and in the setting of critical illness and burn, is a notable risk factor. Applicability of Research to Practice C diff colitis remains a threat to hospitalized and burn patients, for the critically and non-critically ill, and antibiotics treatment could be more aware of the worse consequence.

Decreased Phagocytosis and Intracellular Killing of Bacteria in Leukocytes of Geriatric Patients with Clostridioides difficile Infections

Epidemiological and clinical characteristics of Clostridium difficile infection in patients with refractory inflammatory bowel disease

Clinical Risk Factors For Clostridium Difficile Infection In A Chinese Tertiary Care Hospital

High Incidence and Morbidity of Clostridium Difficile Infection among Hospitalized Patients with Inflammatory Bowel Disease: A Prospective Observational Cohort Study

A Cross-Sectional Study of Clostridium Difficile Infection in Inpatients with Antibiotic Associated Diarrhea

Preservation of the Innate Immune Response to Clostridioides difficile Infection in Hospitalized Immunocompromised Patients

Clinical Characterization and Risk Factors of Clostridium Difficile Infection in Elderly Patients in a Chinese Hospital

Modulation of Lactobacillus Rhamnosus GG on the Gut Microbiota and Metabolism in Mice with Clostridioides Difficile Infection

Advanced age and increased CRP concentration are independent risk factors associated with Clostridioides difficile infection mortality

Disordered Intestinal Microbial Communities During Clostridioides difficile Colonization and Subsequent Infection of Hepatic Cirrhosis Patients in a Tertiary Care Hospital in China

Molecular Characterization and Antibiotic Resistance of Clostridioides Difficile in Patients with Inflammatory Bowel Disease from Two Hospitals in China

Clostridium Difficile Colonization and Infection in Patients with Hepatic Cirrhosis

Impacts of Infection with Different Toxigenic Clostridium Difficile Strains on Faecal Microbiota in Children.

Molecular Characterization and Antibiotic Profile of Clostridium Difficile Isolated from Bacteremia

Risk Factors for Clostridium Difficile Infection in Cirrhotic Patients.

Reduced Clostridioides difficile infections in hospitalised older people through multiple quality improvement strategies

Enterococci enhance Clostridioides difficile pathogenesis

Retrospective analysis of long-term gastrointestinal symptoms after Clostridium difficile infection in a nonelderly cohort

Impact of Antibiotic-Resistant Bacteria on Immune Activation and Clostridioides Difficile Infection in the Mouse Intestine.

Defective macrophage handling of Escherichia coli in Crohn's disease

705 C. difficile Enterocolitis Diagnosis Elevated in Critically Ill Burn Patients Following Antibiotic Treatment